Understanding these mechanisms and targeting ET-1 pathways may offer new therapeutic strategies to address the vascular and inflammatory aspects of epilepsy, potentially improving outcomes for patients with this debilitating disorder. The gene discussed is EDN1; the disease is epilepsy.